Showing results (1241-1250 of 36,551) with videos related to

Sort By:
Pageof 3,656
Frontiers in Oncology|August 28, 2020
Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer PatientsFei Gao, Nan Li, YongMei Xu, et al.
Frontiers in Oncology|August 28, 2020
IMRT and HDR-ICBT for Locally Advanced Clear Cell Adenocarcinoma of the Cervix in Uterus Didelphys Associated With Unilateral Renal AgenesisChengzhi Lei, Manni Huang, Ning Li, et al.
Frontiers in Oncology|August 28, 2020
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK PathwayMengdi Yang, AiTing Wang, Changcan Li, et al.
Frontiers in Oncology|August 28, 2020
Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung CancerYuxin Jiao, Yanping Ren, Weiqiang Ge, et al.
Frontiers in Oncology|August 28, 2020
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast CancerVan T Hoang, Margarite D Matossian, Deniz A Ucar, et al.
Frontiers in Oncology|August 28, 2020
m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling AxisJun-Ju He, Zhi Li, Zhuo-Xian Rong, et al.
Frontiers in Oncology|August 28, 2020
LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE MethylationZhifeng Zhao, Shuxia Liang, Fuguang Sun
Frontiers in Oncology|August 28, 2020
An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular CarcinomaYing Hu, Huaibo Sun, Henghui Zhang, et al.
Frontiers in Oncology|August 28, 2020
Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4María G C Navarrete-Bernal, Mayte G Cervantes-Badillo, Jose Fabián Martínez-Herrera, et al.
Frontiers in Oncology|August 28, 2020
Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic CancerJiahong Jiang, Song Ye, Yaping Xu, et al.
Pageof 3,656